Bull or Bear Market… Doesn’t matter

Kyle Dennis’ new, 5 Min Strategy is poised to double Your Money Weekly!

Michael S. made 173% with Dollar Ace. So can you!


On the watch: Karyopharm Therapeutics Inc. (KPTI)

Kyle DennisKyle Dennis ·

The set-up: Karyopharm Therapeutics Inc. (KPTI) is a clinical-stage biotech focused on therapies for blood cancers. It’s on my radar because they have Phase 2-3 top-line data coming out this fall for a liposarcoma indication on their lead drug, selinexor. Another interesting catalyst is a Phase 2b trial study on selinexor in multiple myeloma, due next April. Another good sign is that analysts at Jefferies Group recently reiterated their “buy” rating on KPTI with a $19 price target, up from $16.

What’s on the chart: KPTI has pulled back pretty significantly since mid-April. On March 2, it hit a high of $13.84, but then the stock got pummeled by a failed selinexor trial for a different indication, and a brief clinical hold imposed by the FDA. Since the beginning of August, it’s been bouncing right above support at $8. It pulled back down to $8.11 on Monday, and then popped up. It looks to me like it could run over $10, maybe to $11, in the next four weeks or so.

How I may play it: I think there should be one more dip back down. On Thursday, it sneaked up when I wasn’t looking, and closed at $9.01. If it falls back down to $8.50, I’d be really interested in picking up a starter position.


Kyle Dennis runs Kyle Dennis’ Biotech Breakouts (biotechbreakouts.com). He is an event-based trader, who prefers low-priced and small-cap biotech stocks. He currently has no shares, options or open orders in KPTI; he last held the stock on June 24, 2016, when he played it as a day trade.

You may also like

Exclusive System Tracks Wall St. Insiders

“Dollar Ace Simply Exposes Information That Wall Street Wants To Keep Quiet” Said Kyle Dennis
“One member, Wesley M., has already reported 360%+ gains in just a few short days. Don’t miss this!”
(Reserve Access Now)

“What Recession?!” Jason Bond nets $55,060 in realized profit in One Day

After going 6 for 6 on profitable trades recently, we caught up with Jason to ask how he did it.
Check out Jason’s exclusive interview revealing this tightly guarded strategy. (Watch Now)

RagingBull.com Co-Founder, Jeff Bishop, Launches High Conviction Trade Service

“We listen to our clients and we give them EXACTLY what they want, so we designed a service to deliver 1 trade, 1 time a week, with a 100%+ PROFIT TARGET, directly to your inbox every Monday before the market opens. (Read More)

Be a Better Stock Trader, Starting Today

Get the expert insights, tips and strategies you need to optimize your trading skills and profiles